Long-Term Human Response Following Subretinal Injection of Recombinant Adenoassociated Virus-sFlt-1 Vector

Status	Finished
Effective start/end date	1/01/11 → 31/12/13

Access Project

Gene Therapy in Neovascular Age-related Macular Degeneration: Three-Year Follow-up of a Phase 1 Randomized Dose Escalation Trial
Constable, I. J., Lai, C. M., Magno, A. L., French, M. A., Barone, S. B., Schwartz, S. D., Blumenkranz, M. S., Degli-Esposti, M. A. & Rakoczy, E. P., 1 May 2017, In: American Journal of Ophthalmology. 177, p. 150-158 9 p.
Research output: Contribution to journal › Article › peer-review
43 Citations (Scopus)
Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration
Constable, I. J., Pierce, C. M., Lai, C. M., Magno, A. L., Degli-Esposti, M. A., French, M. A., McAllister, I. L., Butler, S., Barone, S. B., Schwartz, S. D., Blumenkranz, M. S. & Rakoczy, E. P., 1 Dec 2016, In: EBioMedicine. 14, p. 168-175 8 p.
Research output: Contribution to journal › Article › peer-review

Open Access
90 Citations (Scopus)